InvestorsHub Logo
Followers 10
Posts 448
Boards Moderated 0
Alias Born 12/30/2000

Re: entheos post# 1474

Tuesday, 12/22/2020 12:26:33 PM

Tuesday, December 22, 2020 12:26:33 PM

Post# of 2854
When the latest PR came out and it seem to indicate that nothing major was coming out for the next several weeks, I think investors decided to use it for a tax loss write off.

They currently have five cytokine-derived therapeutic candidates, with a lead compound, SON-080, ready to enter Phase 2 development.
https://www.sonnetbio.com/pipeline

Red this from their website:
"If these studies are successful, we intend to seek a collaboration with an influenza vaccine manufacturer in 2021 to advance the development of a potentially more robust vaccine candidate."

Almost 200 million flu vaccines are produced a year, so the potential is huge.

They have various therapeutics for various diseases.

I have been loading up down here as funds allow.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SONN News